Risk factors predicting Candida infective endocarditis in patients with candidemia

被引:21
作者
Foong, Kap Sum [1 ,2 ]
Sung, Abby [3 ]
Burnham, Jason P. [2 ]
Kronen, Ryan [3 ]
Lian, Qinghua [4 ]
Zetina, Ana Salazar [3 ]
Hsueh, Kevin [2 ]
Lin, Charlotte [3 ]
Powderly, William G. [2 ]
Spec, Andrej [2 ]
机构
[1] Univ Illinois, Coll Med, Sect Infect Dis, Peoria, IL 61656 USA
[2] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, St Louis, MO USA
关键词
Candida infective endocarditis; Candida bloodstream infection; candidemia; STAPHYLOCOCCUS-AUREUS BACTEREMIA; BLOOD-STREAM INFECTIONS; FUNGAL ENDOCARDITIS; INVASIVE CANDIDIASIS; EPIDEMIOLOGY; MANAGEMENT; MORTALITY; DIAGNOSIS; DISEASE; PREVALENCE;
D O I
10.1093/mmy/myz104
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Candida infective endocarditis (CIE) is a rare but serious complication of candidemia. Incidence and risk factors associated with CIE among candidemic patients are poorly defined from small cohorts. Identification of clinical predictors associated with this entity may guide more judicious use of cardiac imaging. We conducted a retrospective analysis of all inpatients aged >= 18 years diagnosed with candidemia at our institution. CIE was diagnosed by fulfilling two of the major Duke criteria: specifically a vegetation(s) on echocardiogram and positive blood cultures for Candida spp. We used univariable and multivariable regression analyses to identify risk factors associated with CIE. Of 1,873 patients with candidemia, 47 (2.5%) were identified to have CIE. In our multivariable logistic model, existing valvular heart disease was associated with a higher risk for CIE (adjusted odds ratio [aOR], 7.66; 95% confidence interval [CI], 2.95-19.84). Predictors that demonstrated a decreased risk of CIE included infection with C. glabrata (aOR, 0.17; 95% CI, 0.04-0.69), hematologic malignancy (aOR, 0.09; 95% CI, 0.01-0.68), and receipt of total parenteral nutrition (aOR, 0.38; 95% CI, 0.16-0.91). The 90-day crude mortality for CIE was 48.9%, similar to the overall non-CIE mortality of 41.9% (P = .338). We identified a set of clinical factors that can predict the presence of CIE among patient with candidemia. These findings may reduce the need for unnecessary expensive and invasive imaging studies in a subset of patients with a lower risk profile for endocarditis and alternative infection source.
引用
收藏
页码:593 / 599
页数:7
相关论文
共 38 条
  • [1] Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy
    Arnold, Christopher J.
    Johnson, Melissa
    Bayer, Arnold S.
    Bradley, Suzanne
    Giannitsioti, Efthymia
    Miro, Jose M.
    Tornos, Pilar
    Tattevin, Pierre
    Strahilevitz, Jacob
    Spelman, Denis
    Athan, Eugene
    Nacinovich, Francisco
    Fortes, Claudio Q.
    Lamas, Cristiane
    Barsic, Bruno
    Fernandez-Hidalgo, Nuria
    Munoz, Patricia
    Chu, Vivian H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 2365 - 2373
  • [2] Candida infective endocarditis
    Baddley, J. W.
    Benjamin, D. K., Jr.
    Patel, M.
    Miro, J.
    Athan, E.
    Barsic, B.
    Bouza, E.
    Clara, L.
    Elliott, T.
    Kanafani, Z.
    Klein, J.
    Lerakis, S.
    Levine, D.
    Spelman, D.
    Rubinstein, E.
    Tornos, P.
    Morris, A. J.
    Pappas, P.
    Fowler, V. G., Jr.
    Chu, V. H.
    Cabell, C.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (07) : 519 - 529
  • [3] Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564
  • [4] Two unlike cousins: Candida albicans and C.glabrata infection strategies
    Brunke, Sascha
    Hube, Bernhard
    [J]. CELLULAR MICROBIOLOGY, 2013, 15 (05) : 701 - 708
  • [5] CALDERONE RA, 1987, REV INFECT DIS, V9, pS400
  • [6] Centers for Disease Control and Prevention, ID HEALTHC ASS INF
  • [7] Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier, C
    Hart, E
    Lefort, A
    Ribaud, P
    Dromer, F
    Denning, DW
    Lortholary, O
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (03) : 384 - 410
  • [8] Fungal endocarditis in bone marrow transplantation: Case report and review of literature
    Chim, CS
    Ho, PL
    Yuen, ST
    Yuen, KY
    [J]. JOURNAL OF INFECTION, 1998, 37 (03) : 287 - 290
  • [9] ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
    Cornely, O. A.
    Bassetti, M.
    Calandra, T.
    Garbino, J.
    Kullberg, B. J.
    Lortholary, O.
    Meersseman, W.
    Akova, M.
    Arendrup, M. C.
    Arikan-Akdagli, S.
    Bille, J.
    Castagnola, E.
    Cuenca-Estrella, M.
    Donnelly, J. P.
    Groll, A. H.
    Herbrecht, R.
    Hope, W. W.
    Jensen, H. E.
    Lass-Floerl, C.
    Petrikkos, G.
    Richardson, M. D.
    Roilides, E.
    Verweij, P. E.
    Viscoli, C.
    Ullmann, A. J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 : 19 - 37
  • [10] Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study
    Diekema, DJ
    Messer, SA
    Brueggemann, AB
    Coffman, SL
    Doern, GV
    Herwaldt, LA
    Pfaller, MA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) : 1298 - 1302